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ABSTRACT
Toxic insult from the heavy metal cadmium is known to induce the expression of
metallothioneins (MT) which are cysteine-rich heavy metal binding proteins six to seven
kilodaltons in size. Previous research demonstrates that over-expression of MT-3 occurs
in the majority of breast cancers and is associated with poor patient outcome.
Furthermore, MT-3 has been shown to inhibit the growth of breast cancer and prostate
cancer cell lines. Studies have shown that the MT-3 protein contains 7 additional amino
acids that are not present in any other member of the MT gene family, a 6 amino acid Cterminal sequence and a Thr in the N-terminal region. The unique N-terminal sequence
is responsible for the growth inhibitory activity of MT-3 in the neuronal system, while
the function of C-terminal region remains unknown. The unique N- and C-terminal
domains of MT-3 may play alternative roles in the differentiation and growth of breast
cancer cells.
One goal of this study was to characterize the function of the N- and C-terminal
domains of MT-3 in the MCF7 breast cancer cell line. For this purpose six different
constructs of MTs were prepared which were as follows: wild type (WT) MT-3, MT-3 Nterminal site directed mutagenesis (MT-3 P7T P9T), MT-3 C-terminal deletion (MT-3
E55_E60del), WT MT-1E, and MT-1E mutated to contain the N -terminal of MT-3 (MT1E N4_C5insTCPCP), or the C-terminal (MT-1E G52_A53insEAAEAE), or both the N-
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and the C-terminal of MT-3 (MT-1E N4_C5insTCPCP and G52_A53insEAAEAE).
Each of these constructs was transfected into MCF7 cells. Both the growth rate and the
transepithelial resistance (TER) of each cell line were measured. Growth rates were
statistically significantly reduced in all cell lines except MCF7 parent, Blank Vector, and
MT-1E. Vectorial active transport was increased in WT MT-3 and mutants containing
the C-terminal of MT-3 as indicated by the formation of domes and increased TER.
Observations of confluent cell cultures of mutant cell lines were also performed to
determine the doming phenotype. Doming was observed in cell cultures possessing the
C-terminal region of MT-3, and the WT MT-3 cell line. The data obtained suggests that
the N-terminal region of MT-3 is involved in growth inhibitory activity even in the
absence of the C-terminal domain. The C-terminal region is involved in vectorial active
transport which is indicated by the formation of domes in cell culture. Depending on cell
culture conditions the N-terminal region of MT-3 may attenuate the C-terminal domain’s
ability to confer the doming phenotype.
Microarray analysis of the MCF7 mutants was also performed to determine
alterations in gene expression. Overlapping hierarchal clustering demonstrates that the
N- and C-terminal mutants have unique expression relationships. Genes that were
differentially regulated on the microarray and were further validated included the GAGE
family antigens. Several GAGE antigens were investigated to examine differential
expression between the N- and C-terminal of MT-3. These included: GAGE12H,
xiii

GAGE12G, GAGE4, GAGE5, GAGE6, GAGE2E-1, GAGE2E-2, GAGE2E-1E, and
GAGE2C. A significant repression of GAGE2C, GAGE2E-1, GAGE2E-2, GAGE5,
GAGE6, and GAGE12H antigen expression was seen in MCF7 mutants NT-1E, WT MT3, and MT-3ΔCT. Up regulation of GAG2C, GAGE2E-2, GAGE5, and GAGE12H
antigens occurred in MCF7 mutants MT-1E and CT-1E. The GAGE12G antigen
demonstrated increased expression in only MCF7 mutant cell lines MT-1E, CT-1E, and
MT-3ΔNT. The GAGE6 antigen was the only antigen to show repression in the presence
of the N-terminal of MT-3 and up regulation in the presence of the C-terminal of MT-3
but not in the presence of MT-1E.
In conclusion, this study further characterizes the unique properties of the N- and
the C-terminal domain of MT-3 and the potential role that it may play in the
differentiation of certain breast cancers. Dendrogram clustering analysis suggests that the
N-terminal and C-terminal domains of MT-3 differentially regulate gene expression in
MCF7 cells. Increased doming activity and increased doubling times of mutant cell lines
containing the C-terminal is suggestive of a differentiated phenotype of the cell line.
Differential regulation of GAGE antigens and E-cadherin in the presence of MT-3 could
be indicative of MT-3’s role in the epithelial to mesenchymal transition of cancer cells.
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CHAPTER I
INTRODUCTION
Overview
This study focused on creating a model system to study the effects that MT-3 and
its unique N- and C-terminal domains have on the growth and differentiation of breast
cancer. This laboratory has previously demonstrated the overexpression of MT-3 is
correlated to a poor diagnostic outcome in breast cancer patients. The creation of MCF7
cell lines expressing the N-terminal, C-terminal, or both of MT-3 followed by the
subsequent microarray analysis will yield insight into the role of MT-3 in the
differentiation of breast cancer. Subsequent investigation into differentially regulated
genes may elucidate targets for breast cancer therapy.
Breast Cancer

There are roughly 232,670 females and 2,360 males diagnosed with breast cancer
every year. Approximately 40,000 females and 430 males die from breast cancer disease
annually as well (Jemal et al. 2002). For women in the United States breast cancer is the
leading cause of mortality from cancer. Over the course of a lifetime one in eight
females will be diagnosed with breast cancer. The BRCA1 and BRCA2 genes are linked
to a high susceptibility of breast cancer but only occur in five percent of breast cancer
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patients (Schmid et al. 1993), while many breast cancers contain point mutations in exons
five through eight of the P53 gene indicating the occurrence may be due to xenobioticinduced mutations (Biggs et al. 1993). This leaves the mechanism of occurrence for the
majority of breast cancers unknown. Evidence suggests that various sources of excess
estrogen correlate to eventual breast cancer development (Henderson et al. 1982).
Obesity also increases the risk of breast cancer by 80% for every 10 kg of body weight
added post menopause (de Waard and Baanders-van Halewijn 1974). Diets high in fiber
rich foods may also reduce breast cancer risk since fiber prevents the intestinal
reabsorption of excreted estradiols (Cohen et al. 1991). Additionally macro- and
micronutrient balance appear to play a role in genomic regulation, and preliminary data
suggest that specific nutrient rich foods have a protective epigenetic effect. Identifying
the influence of environmental toxicants, hormonal exposure, nutrition, and disease on
epigenetics and changes in gene regulation may have potential for development of new
therapeutic approaches for the prevention of breast cancer (Hill and Hodsdon 2014).

There are three main types of breast cancer cases: ductal carcinoma in situ,
invasive ductal carcinoma, and lobular carcinoma in situ. Growth of breast cancer is
often dependent on the overexpression of the estrogen receptor (ER) with seven out of ten
breast cancers being categorized as ER+. Overexpression of the epidermal growth factor
receptor (HER2) occurs in 30% of breast cancer cases and is associated with an
aggressive phenotype (Ross-Innes et al. 2012). Antiestrogens, such as tamoxifen citrate,
inhibit the binding of estradiol to the ER receptor making them useful in the treatment of
ER positive breast cancers (Rockhill et al. 1998). Tamoxifen citrate negates the
stimulatory effects of estradiol, decreases circulating IGF-1 levels, and holds the cell in
2

the G1 phase of the cell cycle (Bernstein et al. 1990). Tamoxifen citrate therapy has been
utilized as a standalone treatment, paired with chemotherapy, or used after chemotherapy
treatment of breast cancer with long-term treatments of more than one year conferring a
survival advantage to patients using the therapy (Henderson et al. 1983).

The MCF7 cell line was isolated from a sixty nine year old Caucasian female, and
is derived from a malignant adenocarcinoma in a pleural effusion (Soule et al. 1973).
The MCF7 cell line is non-doming, ER+, lacks Her2/neu receptor overexpression, has a
karyotype of sixty-six to eighty-seven chromosomes, has an observed doubling time of
twenty-nine hours, and has no basal expression of MT-3 (Gurel et al. 2003). Since the
MCF7 cell line retains the characteristics of the mammary epithelium it is widely used for
in vitro breast cancer studies (Lacroix and Leclercq 2004). The MCF7 cell line is able to
form tumors in athymic mice with estrogen supplementation (Pratt and Pollak 1993).
Knowledge of the signal transduction and molecular biology of estrogen stemmed from
research conducted with MCF7 cells and depended on the cell lines unique properties
(Levenson and Jordan 1997).
Metallothionein
Metallothioneins are a group of intracellular proteins with a high binding affinity
for metals. They are cysteine-rich and are of low molecular weight (six to seven kDa),
and are typically a single polypeptide chain of sixty to sixty-eight amino acids.
Metallothioneins have a unique amino acid composition that consists of twenty conserved
cysteine residues and contain no aromatic amines or histidine. Metallothionein was
initially characterized as a Cd2+ binding protein first isolated from equine kidney cortex
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in 1957 by Margoshes and Vallee (Thirumoorthy et al. 2007). Presently metallothioneins
are classified into four subgroups, MT-1, MT-2, MT-3, and MT-4. In humans the MT
genes are located at chromosome 16q13 and have twelve functional (MT-1A, MT-1B,
MT-1E, MT-1F, MT-1G, MT1H, MT-1L, MT-1M, MT-1X, MT-2A, MT-3,and MT-4)
and four nonfunctional (MT-1C, MT-1D, MT1I, and MT1J) isoforms. Both MT-1 and
MT-2 isoforms are distributed in tissues throughout the human body, whereas MT-3 and
respectively found in the nervous system and kidney, and stratified epithelia (Cherian,
Jayasurya, Bay 2003).
Metallothioneins are physiologically important for the role they play in the
homeostasis of essential metals such as zinc and copper during growth and development
(Cousins 1983). They also provide protection against reactive oxygen species, alkylating
agents, and act to attenuate heavy metal-induced toxicity (Cherian, Jayasurya, Bay 2003).
Metal ions are bound in two distinct clusters, one near the N-terminal which binds three
metal ions to nine cysteine residues, and the other near the C-terminal which binds four
metal ions to eleven cysteine residues (Thirumoorthy et al. 2007) (Figure 1).
Metallothioneins are therefore able to donate zinc or copper to metallo-enzymes and
transcription factors. The binding affinity for metal ions to MTs is Zn2+ < Cd2+ < Cu+ <
Hg2+ < Ag+ = Bi3+. The Zn2+ ion is readily displaced by toxic metal ions enabling MTs to
attenuate the toxic effects of those ions (Miles et al. 2000). Metallothioneins bind Zn2+ in
the human body thus acting as a reservoir of the metal ion for later use. These Zn2+ ions
play a role in various biological processes including DNA synthesis, enzymatic catalysis,
gene expression, and apoptosis. Deregulation of zinc transporters occurs in breast cancer
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and results in an altered level of Zn2+ and MTs in the plasma. The role that Zn2+ and MTs
may play in cancer pathogenesis is still unknown (Gumulec et al. 2011).
The expression of metallothioneins is also associated with protection against
DNA damage and apoptosis. Metallothioneins may function as transcriptional co-factors
by donating zinc, and during cell proliferation and differentiation metallothioneins can
translocate from the cytoplasm to the nucleus (Cherian, Jayasurya, Bay 2003). Increased
expression of metallothioneins has been observed in human liver, lung, kidney, colon,
ovary, prostrate, nasopharynx, testes, salivary gland, thyroid, bladder, and breast tumors.
There is a down regulation of metallothionein expression in hepatocellular carcinoma and
liver adenocarcinoma (Cherian, Jayasurya, Bay 2003).
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Figure 1: Diagram depicting the binding of metal ions in the α and β domain of
metallothionein by thiolate clusters with a representative MT amino acid sequence.
Metal ions are represented by red spheres and sulfur atoms are represented by yellow
spheres. The β-domain is able to bind three metal ions, while the α-domain is able to
bind four metal ions. Adapted from (Ruttkay-Nedecky et al. 2013).
Metallothionein gene expression can be induced by the presence of cytokines,
metals, and hormones (Bremner 1991). Glucocorticoid, antioxidant, cyclic AMP,
interferon, and TPA-responsive elements are present in the promoter region of
metallothionein genes (Samson and Gedamu 1998). The presence of heavy metals
increases metallothionein expression through multiple metal response elements (MREs)
present in the promoter regions of all metallothionein genes (Karin et al. 1984).
Transcription factors found to bind MREs and induce gene expression include the zinc
activated protein, MTF-1, zinc regulation factor, and metal response element binding
factor (Czupryn, Brown, Vallee 1992).
6

The zinc sulfur interaction in metallothioneins provides a chemical basis where
the cysteine group can act as a ligand and carry out oxidoreductive reactions (Maret
2004). Cysteinyl thiolate groups scavenge free hydroxyl and superoxide radical in a
quenching process that involves all twenty cysteine residues, and occurs at a reaction rate
340 fold higher than the rate for GSH (Thornalley and Vasak 1985). Under normal
conditions metallothioneins are concentrated in the cytoplasm, however, after treatment
of cells with hydrogen peroxide, MT-1 MT-2 are rapidly translocated to the nucleus
indicating that they may play a role as a nuclear antioxidant (Takahashi, Ogra, Suzuki
2005).

Figure 2: Metallothionein gene regulation and function. The metallothionein
promoter contains several response elements that regulate transcription. These include
MRE, GRE, ARE, and STAT elements. Adopted from (Ruttkay-Nedecky et al. 2013).
7

Metallothionein-3
This isoform was first identified as a growth inhibitory protein in a study
conducted by Uchida. It was discovered that the survival rate of rat neonatal cortical
neurons cultured with protein extracts from brains with Alzheimer’s disease (AD)
increased in comparison to those supplemented with normal brain extract (Uchida et al.
1991). The increase in neurotrophic activity and survival of the cortical neurons in the
AD brain was due to the absence of this growth inhibitory protein, which decreases
neurotrophic conditions under normal circumstances (Uchida et al. 1991). Further
studies characterizing the molecule eventually revealed that the inhibitory molecule
retained all the classic characteristics of a metallothionein, prompting it to be
redesignated as MT-3 (Tsuji et al. 1992). The growth inhibitory activity is unique to MT3 as none of the other isoforms are associated with this phenomenon (Ding, Ni, Huang
2010). Metallothionein-3 may also play an important role in lysosome function. In the
absence of MT-3 there is a reduction of lysosomal enzymes, and decreased autophagic
flux in astrocytes (Lee and Koh 2010).
Even though MT-3 conserves approximately 70% of the amino acid sequence
found in other MT isoforms, it is structurally unique in comparison to the other isoforms.
The carboxy-terminal region (C-terminal domain) contains a unique acidic hexapeptide
stretch EAAEAE, while an additional threonine residue is present in the amino-terminal
region (N-terminal domain). Those additional seven amino acids are not found in any of
the other MT isoforms (Uchida et al. 1991). The growth inhibitory activity of MT-3 is
abolished by a double mutation in the N-terminal region resulting in the conversion of the
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conserved TCPCP sequence to either TCSCA or TCSCT. This implicates the N-terminal
region of MT-3 in the growth inhibitory activity of MT-3 (Sewell et al. 1995). The
discovery that MT-3 possessed this unique biological property spurred interest into
researching potential biological activities of all the MT isoforms. Transgenic mice
expressing MT-3 ectopically, in the same expression domain of MT-1, died of pancreatic
acinar cell necrosis at 2-3 months of age (Quaife et al. 1998). Transgenic MT-3 knock
out mice exhibited sensitivity to aggravated neuronal damage following a middle cerebral
artery occlusion when compared to WT mice (Koumura et al. 2009). Growth inhibitory
activity of MT-3 outside the neuronal system was demonstrated by stable expression of
MT-3 in kidney, PC-3 prostate cancer cells, MCF7, and T-47D cell lines; however
growth inhibitory activity did not occur when MT-3 was expressed in Hs578T and MDAMB-231 cell lines (Dutta et al. 2002; Gurel et al. 2003).
The EAAEAE insert in MT-3 forms part of the backbone of the molecule and
unlike MT-1/2 is not restricted by the metal-thiolate cluster enabling MT-3 to have a
more dynamic loop conformation (Ding, Ni, Huang 2010). Deletion of the EAAEAE
sequence leads to decreased bioactivity due to the α-cluster being able to constrict further
and alter domain-domain interactions (Ding, Ni, Huang 2010).
Expression of MT-3 was initially thought to be restricted to the central nervous
system, but expression of MT-3 has been detected in the normal human kidney, renal
carcinoma, bladder cancer, and prostatic adenocarcinoma (Albrecht et al. 2008; Cherian,
Jayasurya, Bay 2003). The overexpression of MT-3 in human breast cancer cases has
been correlated to poor prognosis (Sens et al. 2001). Unlike the MT-1/2 isoforms MT-3
expression is not induced by metals; however it has been demonstrated that expression of
9

MT-3 mRNA can be induced transiently, under the control of metal regulatory elements,
in the proximal tubule cells once they are exposed to cadmium (Garrett et al. 2002).
Previous studies provide evidence that MT-3 has specific patterns of expression,
induction, and regulation and that further research into the role of MT-3 in breast cancer
will provide new insights into the function of this metallothionein isoform.
Metallothionein-3 and Breast Cancer
Metallothionein-3 is not expressed in normal breast epithelial cells, but is highly
expressed in the majority of breast tumor samples (Sens et al. 2001). The role that MT-3
plays in the differentiation of breast cancer has yet to be fully described. The MCF7 cell
line has no basal expression of MT-3, and does not form domes in cell culture. The
formation of domes indicates a differentiated phenotype capable of vectorially active
transport (Claude 1978). Overexpression of MT-3 in MCF7 or Hs578T cells results in
growth inhibition while the overexpression of MT-1E does not result in growth inhibition
(Gurel et al. 2003b). Overexpression of MT-3 in cancer cell lines also results in
increased drug resistance (Dutta et al. 2002).
Excess MT-3 may produce an excess of metal-free MT (apoMT) and in so doing
generate a zinc-deficient state. The creation of a zinc-deficient state may result in the
dysregulation of zinc finger transcription factors (Hainaut and Milner 1993; Oren and
Prives 1996; Zeng, Vallee, Kagi 1991) causing cell growth, differentiation, and
programmed cell death to be affected. The zinc-deficient state may also induce a p53null state since apoMT has the potential to sequester zinc from p53 similarly to other zinc
chelators (Garrett et al. 1999). Overexpression of MT-3 in tumors may cause a zinc-
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limiting cellular environment that favors tumor progression despite the slowed cellular
growth (Sens et al. 2001).
The presence of cadmium in human breast cancers indicates that cadmium may
play a role in progression and development of the cancer (Antila et al. 1996). Cadmium
may act as an environmental estrogen by binding to and activating the ER-α receptor
(Garcia-Morales et al. 1994). Zinc was unable to induce the same increase in growth that
cadmium was (Garcia-Morales et al. 1994). Since MT-3 expression is induced by the
presence of cadmium, studying the effect of the presence of MT-3 may yield new insights
into breast cancer biology.
Metallothionein-3 and E-cadherin Expression in HK2 Cells
Fibrosis in chronic renal disease is due to toxic insult from many sources. Such
sources include diabetes and hypertension, and recent evidence suggests that
environmental exposure to the heavy metal nephrotoxin, cadmium, may also contribute to
this process. In renal fibrosis seen in chronic renal disease, nearly one third of the
resident fibroblasts derive from the proximal tubule epithelium, and the process by which
this occurs is termed the epithelial-to-mesenchymal transition (EMT). To better
understand EMT an in vitro model system has been developed that consists of the
normal, immortalized human proximal tubule cell line, HK2. The HK2 cell line lacks
several attributes seen in mortal cultures of human proximal tubules cells such as the lack
of cell junctions, vectorial active transport, and E-cadherin expression, characteristics
which are also exhibited in mesenchymal cells. Restoration of MT-3 expression in this
cell line led to an establishment of cellular junctions, vectorial active transport, and a
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cadherin expression profile that is consistent with an epithelial phenotype (Bathula et al.
2008)(Figure 3). Expression of E-cadherin is essential for this transition due to the role
of E-cadherin in the establishment of adherens junctions, which is required for vectorial
active transport. Current studies suggest that the EMT process itself may be controlled
by MT-3 mediated transcriptional regulation of the E-cadherin gene. E-box elements in
the E-cadherin promoter allow for repression of E-cadherin (Batlle et al. 2000).

Figure 3: Dome formation by vectorial active transport. Dome formation occurs
when a monolayer of epithelial cells differentiates to possess apical and basolateral
surfaces (Lever Julia 1985). E-cadherin expression is required, and loss of transport
occurs during renal fibrosis. Figure adapted from (Lever Julia 1985).
12

GAGE Antigens
Cancer/testis (CT) antigens are a group of proteins normally expressed in human
germline cells and are present in various tumor types. Currently there are eighty nine CT
antigens all of which are encoded on the X chromosome (Gjerstorff and Ditzel 2008).
The GAGE antigens are a family of CT antigens consisting of at least sixteen different
genes, which are further divided into three groups based on their unique properties and
are located on chromosome X at p11.23 (De Backer et al. 1999). GAGE-1 contains a Cterminal sequence not found in any of the other seven members. The remaining members
have amino acid sequences that are 98% identical, but can be divided into two separate
groups. GAGE-2 and GAGE-8 do not contain a tyrosine residue that may be
phosphorylated (Y9), while GAGE-3-7 and GAGE-1 do not possess the same tyrosine
residue (Salomon et al. 2003). The promoters of the GAGE antigen family have no
TATA box, and have only one or two different base pairs in the first fourteen hundred
base pairs (Gjerstorff and Ditzel 2008). The lack of a TATA box site for initiation allows
transcription to start from several different sites leading to transcripts of varying lengths
(Cilensek et al. 2002).
The exact biological function of the GAGE antigens has yet to be fully elucidated,
but recent evidence suggests that they may direct cell proliferation, differentiation, and
the survival of germ line cells (Simpson et al. 2005). Antiapoptotic properties have also
been attributed to GAGE antigens (Cilensek et al. 2002). Expression of the GAGE
antigens normally occurs in a subset of oocytes in the adult ovary (Gjerstorff et al. 2006),
adult male germ cells, and for a few weeks in fetal Leydig and Sertoli cells during the
third trimester (Gjerstorff et al. 2007). GAGE gene transcripts are present in numerous
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types of cancers including 26% of breast cancers (Gjerstorff et al. 2006).
Immunohistochemical analysis reveals a lower level frequency of GAGE antigen
presence and a high degree of tumor heterogeneity (Kobayashi et al. 2000). The
expression of GAGE antigens in stomach cancer, neuroblastoma, and esophageal
carcinoma has been correlated with a poor prognosis and an aggressive tumor type
(Cheung, Chi, Cheung 2000; Kong et al. 2004; Zambon et al. 2001). Since most normal
tissues do not express GAGE antigens and areas of normal expression are immuneprivileged sites this makes them potentially useful targets as diagnostic and prognostic
indicators, and as potential targets for immunotherapy treatment (Gjerstorff and Ditzel
2008).

Matrix Metalloproteinases

Matrix metalloproteinases (MMPs) are a family of zinc dependent extracellular
proteases that can completely remodel the extracellular matrix (ECM) allowing MMPs to
function in a variety of biologic processes (Yadav et al. 2014). These biological
processes include: cytokine modulation, angiogenesis, growth factor bioavailability, cell
migration, cell proliferation, receptor shedding, invasion, metastasis, and apoptosis (Roy
and Walsh 2014). The epithelial to mesenchyme transition (EMT) is a multistage process
in which alteration of the microenvironment and cell differentiation is required for
metastasis to occur. During carcinogenesis MMPs act as mediators of alterations
observed in the microenvironment during both early and late stages of disease
progression (Yadav et al. 2014). In breast cancer MMPs are over expressed prior to
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EMT, but treatment of cells with centchroman reversed EMT by downregulating the
HER2/ERK1/2/MMP-9 pathway (Khan et al. 2015).
Leucine-Rich Repeat-Containing Proteins
Leucine rich repeat containing (LRRC) proteins are a family of proteins known to
be involved in protein-protein interactions and contain multiple LRR motifs of twenty to
thirty amino acids. The protein LRRC49 is a member of this family of proteins and has
been shown to have elevated expression levels in ER+ breast cancers compared to ERbreast cancers, however its role in the differentiation of breast cancer remains unknown
(De Souza Santos et al. 2008).
Neural Tissue-specific Epidermal Growth Factor-like Repeat Domain-containing
Protein
Neural tissue-specific epidermal growth factor-like repeat domain containing
protein two (NELL2) was first discovered as a mammalian homolog to the chicken NEL
protein. It has been found to be expressed in neurons. NELL2 may play a role in
neuronal development, postnatal neural activity, and in cancer cell survival.
Overexpression of NELL2 occurs in Burkitt’s lymphoma and in neuroblastomas (Maeda
et al. 2001). Recent studies have revealed that the expression of NELL2 is regulated by
the oncogene E2F1 (Kim et al. 2013). The E2F1 oncogene is a key regulator of cell
proliferation. Overexpression of NELL2 also increases the invasive activity of MCF7
and MDA-MB-231 cells (Kim et al. 2013).

Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthetase 2
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Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthetase 2 (PAPSS2) is an
enzyme that acts as a sulfur donor and catalyzes the transfer of sulfur to other molecules
in a process known as sulfation. Estrogen is metabolized and inactivated in target tissues
via sulfation effectively inactivating the molecule to elicit growth. It has been
demonstrated that overexpression of PAPSS2 in MCF7 slows cellular proliferation both
in vivo and in vitro arresting cell cycle progression and inducing apoptosis (Xu et al.
2012).

Glycogen Phosphorylase

The metabolic enzyme glycogen phosporylase (PYGL) plays a role in the
metabolic reprogramming of cancer cells. In the hypoxic environment of a growing
tumor glycogen metabolism is upregulated (Favaro et al. 2012). The degradation of
glycogen by PYGL is necessary for the function of the pentose phosphate pathway and
cells without sufficient levels of PYGL undergo senescence (Favaro et al. 2012).
Inhibition of PYGL and the subsequent metabolic alterations induces senescence in
glioblastomas making it a potential therapeutic target (Abbadi et al. 2014).

Voltage-Gated Sodium Channels

Voltage gated sodium channels (VGSCs) are normally expressed in cells of the
nervous system, and are responsible for the rising phase of action potentials (Pablo and
Pitt 2014). Expression of VGSCs also occurs in various metastatic cells and in specific
cancer cell lines including the prostate (Shan et al. 2014). Expression of the α subunits of
the sodium channels Nav1.6 and Nav1.7 were found to be six to twenty-seven times
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higher in PC-3 and LNCaP cells than in cells of benign prostatic hyperplasia (Shan et al.
2014). The overexpression of these subunits could serve as both a therapeutic target and
prognostic biomarker.

Statement of Purpose
This study is designed to further elucidate the role of MT-3 in the regulation of
cell differentiation in breast cancer. The study aims to elucidate the role that the unique
N- and C-terminal domains of MT-3 may play in the differential expression of genes
involved in the progression of breast cancer. MT-3 has been shown to be overexpressed
in poor prognosis breast cancers (Sens, et al 2001), and has been shown to inhibit the
growth of breast cancer and prostate cancer cell lines stably expressing MT-3 (Gurel, et
al 2003). When compared to other MT isoforms MT-3 contains an additional Thr in the
N-terminal region and an acidic hexapeptide sequence EAEAAE in the C-terminal
domain not found in other members of the MT gene family. It was determined that the
non-doming MCF7 cell line would be used to study MT-3 and its role in breast cancer
since MCF7 cells have no basal expression of MT-3.

In order to characterize the function of the N- and C-terminal domains of MT-3 in
the MCF7 breast cancer cell line six different constructs of MTs will be prepared as
follows: wild type (WT) MT-3, MT-3 N-terminal point mutation (MT-3 P7T P9T), MT-3
C-terminal deletion (MT-3 E55_E60del), WT MT-1E, and MT-1E insert mutation to
contain the N -terminal of MT-3 (MT-1E N4_C5insTCPCP), or the C-terminal (MT-1E
G52_A53insEAAEAE), or both the N- and the C-terminal of MT-3 (MT-1E
N4_C5insTCPCP and G52_A53insEAAEAE). Each of these constructs will be
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transfected into MCF7 cells and three cell lines with the highest expression levels as
determined by real time PCR and dot blot determination of protein levels will be utilized
for observations. Cell cultures will be observed for the formation of domes, doubling
times will be determined using the MTT method, and the transepithelial resistance (TER)
of each cell line will be measured to determine if vectorially active transport is occurring.
Microarray analysis of the MCF7 mutants will also be performed to determine
alterations in global gene expression. The bioinformatics core at the University of North
Dakota School of Medicine and Health Sciences will analyze the microarray results for
differentially expressed genes in the MCF7 mutant cell lines. Overlap hierarchal
clustering will be utilized to demonstrate and visualize the expression relationship
between the N- and C-terminal mutants. Differentially expressed genes based on
microarray analysis will be confirmed by real time PCR. This study may provide
evidence regarding MT-3’s role in the differentiation of breast cancer, and elucidate the
role the N- and C-terminal domains of MT-3 play in differentiation.
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CHAPTER II
MATERIALS AND METHODS

Reagents

TRI Reagent and bromo-chloropropane (BCP) Phase separation reagent were
purchased from Molecular Research Center, Inc. (Cincinnati, OH) 1.5 M Tris-HCl,
ammonium persulfate, TEMED, Laemmli sample buffer, 0.5 M Tris-HCl, SYBR green
PCR kits, cDNA synthesis kits, and pre-cast PAGE-gels were purchased from BIO-RAD.
(Hercules, CA) Albumin standards and BCA protein assay reagents were purchased from
Pierce (Rockford, IL). Glutaraldehyde solution, isopropanol, methanol, ethanol, DMEM
nutrient, and F12 nutrient were purchased from Sigma-Aldrich (St. Louis, MO). Fetal
calf serum, penicillin-streptomycin 10,000 U/mL, and trypsin–ethylenediaminetetraacetic
acid (0.05%, 0.02%) were purchased from Gibco (Life Technologies, NY). Hydrophilic
Polytetrafluoroethylene trans-well inserts designed for 6-well cell culture dishes were
obtained from Millipore (EMD Millipore, MA). For the microarray analysis the
HumanHT-12 v4 Expression BeadChip (Illumina, CA) was selected.
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METHODS
Cell Culture
The MCF7, and Hs578-T cells were obtained from American Type Culture
Collection (Rockville, MD), and grown in Dulbeco’s Modified Eagles Medium (DMEM)
(which contains 1000 mg/L glucose and L-glutamine, supplemented with 100 units/mL
penicillin, 100 µg/mL streptomycin, 0.25 amphotericin B, 0.205 µg/mL sodium
deoxycholate, and 3.7 g/L sodium bicarbonate) supplemented with 5% (v/v) fetal calf
serum, 5 mg/ml glucose and routinely passaged at a 1:4 ratio upon attaining confluence.
HK2 and HK2-MT3 cells were cultured using a growth formulation consisting of a 1:1
mixture of DMEM and Ham's F-12 (which contains L-glutamine 0.146 g/L,
supplemented with 100 units/mL penicillin, 100 µg/mL streptomycin, 0.25 µg/mL
amphotericin B, 0.205 µg/mL sodium deoxycholate, and 3.7 g/L sodium bicarbonate)
growth medium supplemented with selenium (5 ng/ml), insulin (5 μg/ml), transferrin (5
μg/ml), hydrocortisone (36 ng/ml), triiodothyronine (4 pg/ml), and epidermal growth
factor (10 ng/ml). MCF7 cells and Hs578-T cells were fed every 3 days. HK2 and HK2MT3 cells were fed fresh growth medium every 3 days and 2 days respectively. The cells
were kept in various tissue culture vessels at a constant temperature of 37° C in a 5% CO2
: 95% atmosphere. Medium was always replaced with fresh medium 24 h prior to
subculturing. Upon obtaining confluency, cells were subcultured in the following
manner: culture medium was aspirated and the cells were rinsed twice with sterile PBS
(37° C) then trypsin–ethylenediaminetetraacetic acid (0.05%, 0.02%) (Life Technologies,
NY) was added to the vessel. The cells were monitored until disassociation from the
bottom of the culture vessel occurred. The cell suspension was then transferred to a
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conical tube containing fetal calf serum (Gibco, Mexico) using additional PBS to suspend
and transfer the cells. A cell pellet was obtained by a five min centrifugation at 2,000
rpm followed by the removal of the supernatant. Cell pellets were resuspended in an
appropriate volume of medium, and then seeded in the desired culture vessel. Culture
vessels were then placed in the incubator and cells were evenly distributed by gentle
shaking in horizontal and vertical directions.
Electroporation
Transfection of HK2 and HK2-MT3 cells was performed with Amaxa Cell Line
Nucleofector Kit V (Amaxa, NJ) according to the manufacturer’s protocol. Cells were
suspended in Nucleofector Solution to a final concentration of 3×106 cells/100 μl. The
cells were transfected using 2 μg of the Luciferase reporter construct, and 0.2 µg of the
Renilla reporter construct. (Promega, WI) In amaxa-certified cuvettes, the cells were
nucleofected using the program T-020. The nucleofected cells were transferred to 2000
μL of prewarmed medium in 6-well plates after adding 500 µL prewarmed medium
directly to the cuvette, and incubated for 36 h.
E-Cadherin Promoter Constructs
Vector Construction
Wild Type Promoter Region of E-cadherin
CCCATAACCCACCTAGACCCTAGCAACTCCAGGCTAGAGGGTCACCGCGTCT
ATGCGAGGCCGGGTGGGCGGGCCGTCAGCTCCGCCCTGGGGAGGGGTCCGC
GCTGCTGATTGGCTGTGGCCGGCAGGTGAACCCTCAGCCAATCAGCGGTACG
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GGGGGCGGTGCCTCCGGGGCTCACCTGGCTGCAGCCACGCACCCCCTCTCAG
TGGCGTCGGAACTGCAAAGCACCTG
E-cadherin Promoter with Mutated E-boxes
CCCATAACCCACCTAGACCCTAGCAACTCCAGGCTAGAGGGTCACCGCGTCT
ATGCGAGGCCGGGTGGGCGGGCCGTCAGCTCCGCCCTGGGGAGGGGTCCGC
GCTGCTGATTGGCTGTGGCCGGAACCTAAACCCTCAGCCAATCAGCGGTACG
GGGGGCGGTGCCTCCGGGGCTAACCTAGCTGCAGCCACGCACCCCCTCTCAG
TGGCGTCGGAACTGCAAAGAACCTA
Mutated E-box regions are in bold. The WT E-boxes and mutated E-box regions are
underlined and the transcription start site is a single underline A. The above sequences
were ligated into the multiple cloning region of the pGL4.10[luc2] vector (Promega, WI)
by GenScript (Piscataway, NJ). The desired promoter sequence, length, and mutation of
the E-boxes are based on research previously conducted by Batlle (Batlle et al. 2000b).
Sequence design for ligation was done utilizing Vector NTI® computer software (Life
Technologies, NY).
Luciferase Assay
The HK2 and HK2-MT-3 cell lines were transfected with the promoter reporter
constructs previously described. Transfected cells were rinsed with prewarmed PBS
once, before adding 500 µL of Promega’s supplied lysis buffer PLB. Cells were gently
rocked for fifteen minutes to allow for complete lysis. A total of 20 µL of cell lysate was
added to 100 µL of Luciferase assay reagent, and the intensity of luminescence was
measured using the Biotek FLx800 plate reader. The Luciferase reaction was then
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quenched using 100 µL of Promega’s Stop and Glo buffer, and then the luminescence of
the Renilla was measured. Lysates were measured four separate times per
electroporation reaction. The use of the Renilla reporter under the thymidine kinase
promoter was used to normalize for transfection efficiency.
Stable Transfection of MCF7 Cells
The WT MT-3, WT MT-1E, MT-3ΔNT (MT-3 P7T P9T), MT-3ΔCT (MT-3
E55_E60del), and NT-1E (MT-1E N4_C5insTCPCP), CT-1E (MT-1E
G52_A53insEAAEAE), and CT-NT-1E (MT-1E N4_C5insTCPCP and
G52_A53insEAAEAE) were blunt end ligated into the 6.2/V5 Destination vector
(Invitrogen, NY) were linearized using BspHI (New England Biolabs, MA) prior to
transfection using Effectene reagent (Qiagen, CA) (Figure 4). Sequence design for
ligation was done utilizing Vector NTI® computer software (Life Technologies, NY).
Generation of the mutant sequences and ligation the genes was conducted by GenScript
(Piscataway, NJ) using the WT MT-3 gene sequence. Plasmids were transformed using
One Shot® TOP10/P3 E. coli cells (Life Technologies, NY) and purified using a Qiagen
midi prep kit (Qiagen, CA).
Transfected cells were allowed to reach confluency in one well of a 6-well plate
and then subcultured at a 1:10 ratio into a 6-well plate. Transfected cells were
propagated using media containing 10 µg/mL blasticidin (Invitrogen, CA) and observed
for the formation of small isolated colonies. Twenty four colonies were selected for each
construct by using cloning rings that held 200 µL in volume (Sigma Aldrich, MO) and
were always exposed to media containing 10 µg/mL blasticidin (Invitrogen, CA).
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Selected colonies were subcultured into one well of a 24-well plate. Upon attaining
confluency transfected cells were subcultured into one well of a 12-well plate for a 1:2
split ratio. Colonies of transfected cells were subcultured a final time into a 6-well plate
prior to a portion of the cells being harvested for mRNA isolation. Cell lines expressing
1x105 copies of the mRNA per 10 ng RNA were selected using qRT-PCR. Protein
expression for each cell line was determined using the dot blot method, and the three cell
lines expressing the highest amount of protein were selected for downstream applications.
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Figure 4: Visual representation of the gene constructs generated to further examine
the role of the unique N- and C-terminal domains of MT-3. Constructs of MTs were
prepared which were as follows: wild type (WT) MT-3, MT-3 N-terminal mutation (MT3 P7T P9T), MT-3 C-terminal deletion (MT-3 E55_E60del), WT MT-1E, and MT-1E
mutated to contain the N-terminal of MT-3 (MT-1E N4_C5insTCPCP), or the C-terminal
(MT-1E G52_A53insEAAEAE), or both the N- and the C-terminal of MT-3 (MT-1E
N4_C5insTCPCP and G52_A53insEAAEAE).
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Transfection of MCF7 Cells Using Qiagen Effectene
Cells were split 24 h prior to transfection and were allowed to achieve 40-60%
confluency. A 1:10 ratio of DNA to Effectene was utilized for the procedure. Linearized
DNA was diluted to .1 µg/µL in Tris-EDTA, and a total of 1 µg DNA was used per
transfection. Qiagen supplied all needed reagents the formulation of which is proprietary.
Diluted DNA was combined with 90 µL of buffer EC and 4 µL of Enhancer. The
combination was mixed, spun down briefly, and incubated at room temperature for 2-5
minutes. A total of 10 µL Effectene was added to the mixture, incubated for 5-10 min at
room temperature, and then combined with 400 µL media prior to being added to the
cells. Before the DNA and Effectene complex was added to the cells they were rinsed
once with PBS and had fresh media added to the culture vessel.
Doming Observations for MCF7 Cell Lines
MCF7 parent and MCF7 mutant cell lines were seeded at a 1:3 ratio in triplicate
into T-25 flasks without vented caps. Cells were all fed on a standard schedule and flasks
were observed for domes once the culture obtained confluency. Dome formation
observation began 6 days post seeding. A dome is considered formed when a group of
several cells appears out of focus in relation to the monolayer, and when some portion of
the dome is in focus the rest of the monolayer will appear out of focus. A field of view
using a 10x objective has a surface area of 1,180,370.75 µm2. Flasks were scanned and
when doming was observed that field of view and all the domes in it were counted. A
dome was only allowed to be counted once in one field of view. Doming cultures had
twenty-one field of views observed per T-25 culture flask.
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Measurement of Transepithelial Resistance
MCF7 parent and MCF7 mutant cell lines were seeded at a 1:2 ratio in triplicate
onto 30-mm-diameter cellulose ester membrane inserts (Millipore, MA) placed in sixwell trays. Beginning on the third day post-seeding, TER was measured every day with
the EVOM Epithelial Voltohmmeter with a STX2 electrode set according to the
manufacturer’s instructions (World Precision Instruments, FL). This instrument
measures the resistance to an alternating current flow through the filter containing the
monolayer of cells. The resistance of the bare filter containing medium was subtracted
from that obtained from filters containing cell monolayers. Two sets of four readings
were taken at four different locations on each filter.
Determination of Doubling Times
Forty microliters of 5 mg/mL 3-(4,5-Dimethylthiazol-2-yl)-2,5
diphenyltetrazolium bromide (MTT) (Sigma Aldrich, MO) was added to the media of
cells plated at a 1:100 ratio. After 3.5 h the cells were washed once with PBS, and the
formazan crystals were solubilized in acidic propanol. Absorption at 570 nm was
determined. Increases of absorption during the logarithmic growth phase were used to
calculate doubling times.
Dot Blot and Protein Extraction Method Specific for Dot Blot
Determination of MT-3 protein content per microgram of total protein was
accomplished by immunoblotting. Cells were rinsed twice with PBS, and harvested in a
buffer containing 10 mM Tris pH 7.4 and 75 mM NaCl. Lysis of the cells was
accomplished by freezing the cells for 30 seconds in liquid nitrogen followed by rapidly
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thawing the cells in 37°C water. The freeze thaw process was repeated three times.
Samples were then centrifuged at 15,000xg for 15 minutes at 4°C the supernatant was
collected for further use. Protease inhibitors and a final concentration of 1 mM DTT was
added to each sample. A total of 2 µg of protein lysate in PBS and 1.5% glutaraldehyde
was transferred to the dot-blot apparatus. The protein lysate was transferred onto a
PVDF membrane by gravity flow. Samples were rinsed twice with PBS after having
entered the membrane. The membrane was then stained for MT-3 using the following
dot blotting protocol: the membrane was blocked using 1% BSA in PBS, following
which the membrane was incubated with the primary MT-3 antibody at a 1:100 dilution
in 1% BSA in PBS. After incubation with the primary antibody the membrane was
washed a couple of times and then incubated with the secondary anti-mouse alkaline
phosphatase-conjugated secondary antibody (Promega, WI) at a 1:500 dilution in .4%
BSA in PBS. The antigen-antibody complexes were visualized using the alkaline
phosphatase KI III (Vectore, CA). The membrane was washed three times for 15 minutes
in PBS between every step.
Cell Culture Harvest
Confluent cell cultures were harvested in the following manner: cell culture
vessels were rinsed twice with 10 mL PBS, 1.5 mL of PBS was added and the cells were
mechanically scraped from the vessel, the suspension was then added to a 1.5 mL
microfuge tube and pelleted at 2,000 rpm for 5 min at 4°C, the supernatant was aspirated
and the remaining pellet was stored at -80°C for later use.
Preparation of RNA for Microarray Analysis
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Qiagen RNeasy Mini Kit (Qiagen, CA) was used to prepare RNA samples for
mincroarray analysis. Media was aspirated off of confluent T-75 flasks (Corning, NY)
and 3 mL of lysis buffer RLT containing 10 µL of 14.3M betamercaptoethanol per mL
was added. The QiaShredder column was used to homogenize 700 µL of the lysates. An
equal volume of 70% ethanol was added to the homogenized lysate, and 700 µL was
added to the RNeasy mini column. The column was centrifuged at 10,000 x g for 15
seconds after which the eluate was discarded. A total of 700 µL buffer RW1 was added
to column, centrifuged for 15 seconds at 10,000 x g, and the eluate was discarded. The
RNeasy column was transferred to a new collection tube and the following step was done
twice: 500 µL buffer RPE was added, centrifuged for 15 seconds at 10,000 x g, and the
eluate was discarded. To remove all traces of remaining reagents the column was
centrifuged for 1 minute at 10,000 x g with nothing added. Elution of the RNA was
accomplished by adding 50 µL of RNase free water and allowing the column to
equilibrate at room temperature prior to centrifugation for 1 minute at 10,000 x g.
RNA Isolation Using TRI Reagent
RNA isolation for purposes other than microarray analysis was performed using
TRI reagent (Molecular Research Center Inc., OH). Following the removal of the media
an appropriate volume of TRI reagent was added to the cells. Cells were incubated at
room temperature for 10 minutes with gentle rocking to ensure complete lysis. The cell
lysates was then pipetted repeatedly to shear the DNA prior to its transfer to an RNase
free microfuge tube. A total of 100 µL BCP was added per 1 mL of TRI reagent and the
samples were vortexed for a minimum of 30 seconds to ensure complete mixing.
Samples were incubated at room temperature for a minimum of 5 minutes prior to being
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centrifuged at 12,000 x g for 15 minutes at 4°C. The upper aqueous phase was
transferred to a new tube and 500 µL of isopropanol was added. Precipitated RNA was
pelleted by centrifugation at 12,000 x g at 4°C. Supernatant was removed and the RNA
was washed twice with 75% ethanol followed by a centrifugation step at 7,500 x g for 5
minutes at 4°C. The RNA pellet was air dried for 2 minutes and resuspended in 30 µL of
RNase free water.
Determination of DNA and RNA Concentrations
The concentration of DNA- or RNA-containing samples was determined using a
Nano Drop (Thermo Scientific, TN) spectrophotometer and supplied computer software.
Extinction coefficients were selected depending on if the sample was DNA or RNA. The
software determined the concentration of the nucleic acid based on the absorbance at 260
nm of a 1 µL sample loaded onto the pedestal. The A260/280 ratio was also examined to
determine the quality of the sample.
Determination of Protein Concentration of Cell Lysates
The protein concentration of sample lysates was determined using Bradford
reagent (Bio-Rad, CA) or using the BCA assay (Pierce, IL). To make the working
solution 1 part BCA reagent B was combined with 50 parts BCA reagent A, 200 µL of
the working reagent was combined with 5 µL of the protein sample and 20 µL of distilled
water, and incubated at 37°C for 30 min. A 1x working solution was made from 4.5x
Bradford reagent and 180 µL of working reagent was combined with 15 µL distilled
water and 5 µL of the protein sample. Bovine serum albumin standards at concentrations
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of 0, 0.1, 0.2, 0.4, 0.6, 1.2, .1.6, and 2 µg/µL were used to make the standard curve.
Absorbance was measured at 570nm on a BioTek ELx800 (BioTek, VT).
cDNA Synthesis
Conversion of RNA to cDNA was accomplished using the iScript cDNA
Synthesis Kit (Bio-Rad, CA). Per 20 µL reaction 5 µL of 20 ng/µL RNA was mixed with
4 µL 5x iScript reaction mix, 1 µL iScript reverse transcriptase, and 10 µL nuclease free
water. The reaction was incubated using a thermocycler for 5 min at 25°C, 30 min 42°C
and 5 min at 85°C followed by storage at -20°C.
Real-time PCR Analysis Protocol for Bio-Rad Assays
Gene expression was assessed with real time RT-PCR utilizing gene-specific
primers (Bio-Rad, CA). Real-time PCR was performed utilizing the SYBR Green kit
(Bio-Rad, CA) with 2 μl of cDNA, 1 μL primers in a total volume of 20 μl in CFX realtime detection system (Bio-Rad, CA). Cycling conditions were 94 ºC denaturation, 60ºC
annealing, and 72 ºC extension. Amplification was monitored by SYBR Green
fluorescence and compared with that of a standard curve consisting of serial dilutions of
the control cDNA (Blank Vector MCF7 cells). Gene expression is expressed as fold
change compared to the control.
Microarray Analysis
RNA isolated from each MCF7 mutant cell line using RNeasy Mini Kit (Qiagen,
CA) was sent to the University of Minnesota Genomics Center for microarray
hybridization. HumanHT-12 v4 Expression BeadChip (Illumina, CA) was utilized to
31

determine genome wide gene expression levels. The Bioinformatics core facility at the
University of North Dakota School of Health and Medicine Sciences analyzed the
resulting data for differentially expressed genes. Hierarchical clustering and principal
components analysis were used to assess the similarity and variation across isolates. The
fold change of each probe in each array from a transformed cell line was calculated over
its average expression level in the parental MCF7 and MCF7 Blank Vector cell line. In
order to test whether transformed isolates have a nonrandom set of overlapping probes,
we derived a probability function for the random number of overlapping probes, and used
simulation test to find the statistical significance of the observed number of overlapping
probes. Differentially expressed probe sets (DEGs) were identified using empirical Bayes
method (Smyth 2004) and the p-values were adjusted using false discovery rate
(Strimmer 2008). The analyses were carried out using R programming language and SAS
JMPH software.

Transformation
Plasmids received from Genscript (Piscataway, NJ) were transformed and
propagated using One Shot® TOP10/P3 E. coli cells (Life Technologies, NY) as follows.
An aliquot of E. coli cells were thawed on ice prior to adding 1 µL of 1µg/µL plasmid
DNA in TE at pH 8.0. Cells were incubated on ice for thirty minutes and heat shocked in
a water bath at 42°C for thirty seconds. Cells were placed back on ice for two minutes,
prior to the addition of 250 µL room temperature S.O.C. medium. Tubes were capped
and incubated with shaking at 37°C for sixty minutes. Each transformation was plated
onto LB agar plates containing 100 µg/mL ampicillin and incubated at 37°C for no less
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than 12 hours. Individual colonies were selected for propagation in LB media prior to
plasmid isolation.
Plasmid Isolation
The Qiagen Midi Prep Kit (Qiagen, CA) was utilized to isolate plasmid DNA for
downstream applications. An individual transformed colony was incubated in sterile LB
media containing 10 g tryptone, 5 g yeast extract, 10 g NaCl, and 0.1 g ampicillin per
liter at 37°C for 8-12 hours while shaking at 300 rpm. Cells were pelleted by
centrifugation at 6000 x g for 15 minutes at 4°C, and resuspended in buffer P1 containing
RNase A. Buffer P2 was added, mixed by inversion, and incubated at room temperature
for five minutes. Buffer P3 was chilled to 4°C, added, mixed by inversion, and incubated
on ice for five minutes. A QIAGEN-tip was equilibrated with buffer QBT prior to having
the plasmid mixture applied. The QIAGEN-tip was washed twice with buffer QC, and
the DNA was eluted using buffer QF. Precipitation of the DNA was accomplished by
adding isopropanol, and centrifuging at 15,000 x g for thirty minutes at 4°C. The DNA
pellet was washed using 70% ethanol and centrifuged at 15,000 x g for 10 minutes at 4°C.
Supernatant was aspirated and the pellet was air dried for 10 minutes prior to being
dissolved in TE buffer and pH 8.0.
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CHAPTER III
RESULTS
Metallothionein-3 Mediated Control of E-cadherin Expression Through E-box
Promoter Elements
Previous research has indicated that E-cadherin expression is down-regulated by
the binding of the transcription factors slug and snail to promoter elements called Eboxes (Batlle et al. 2000). Expression of MT-3 in HK2 cells restores vectorial active
transport and is accompanied by an increase in the expression of E-cadherin (Bathula et
al. 2008). The relationship between the expression of MT-3 and E-cadherin was
examined using a luciferase construct containing 205 base pairs upstream of the Ecadherin gene start site and twenty-seven base pairs past and including the start site. This
region contains three E-box elements capable of interacting with the transcription factors
slug and snail. Mutation of the E-boxes prevents transcriptional repression by slug or
snail (Batlle et al. 2000). A construct with all three E-boxes mutated to prevent binding
and a WT version were both transfected into WT HK2 cells or HK2 cells stably
expressing MT-3 (HK2-MT-3). Thirty-six hours post-transfection, cells were assayed to
determine the relative activity of each promoter based on the amount of Luciferase
produced, and normalized for transfection efficiency by measuring the luminescence of
Renilla expressed using the thymidine kinase promoter.
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The presence of MT-3 significantly increased E-cadherin expression levels in the
case of the WT E-cadherin promoter construct and the mutated E-boxes promoter
construct (Figure 5). Normalized luminescence was 66.13 +/- 2.53, 100.37 +/- 35.16,
135.87 +/- 42.63, and 214.7 +/- 55.03 for the WT promoter, WT promoter with MT-3,
Mutated E-box promoter, and Mutated E-box promoter with MT-3 respectively. Data
indicates a 47.65% increase in expression was observed in HK2 cells expressing MT-3
versus WT HK2 cells when transfected with the WT E-cadherin promoter construct,
while the mutated E-box promoter construct had an 81.71% increase in expression over
the WT construct in WT HK2 cells, and a 116.32% increase in expression in HK2 MT-3
cells. In HK2 cells a statistically significant increase in expression occurred when the
WT E-cadherin promoter is compared to the E-cadherin promoter with mutated E-boxes
(Figure S1). A statistically significant increase also occurs when comparing the
expression increase of HK2 to HK2-MT-3 cells transfected with the WT E-cadherin
promoter (Figure 5). Additionally, a statistically significant increase in expression occurs
in the HK2-MT-3 cell line when comparing the WT E-cadherin promoter to the Ecadherin promoter containing mutated E-boxes (Figure S2).
In HK2 cells mutation of the E-boxes in the E-cadherin promoter leads to a
significant increase in E-cadherin expression (Figure S1). The presence of MT-3
increases E-cadherin expression significantly for the WT E-cadherin promoter and the
mutated E-boxes promoter (Figure S2). Data suggest that E-cadherin expression is
modulated by the presence of MT-3 regardless of the status of the E-box elements.
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Figure 5: Comparison of both WT and Mutant E-box E-cadherin promoter
constructs in both HK2 and HK2-MT-3 cell lines. Both constructs were transfected
into HK2 and HK2-MT-3 cell lines and are represented on the X axis. Data are
expressed as a ratio of the Luciferase signal to the Renilla signal on the Y axis. Error
bars represent the standard error of the mean (SEM). Statistical significance indicated by
* P-value less than 0.05 as determined using the one-way ANOVA as the test where N=3
biological replicates. Each condition is statistically significantly different in comparison
to all other conditions. The HK2 cell line transfected with the WT E-cadherin promoter
is utilized as the official control.
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Doming Characteristics of MCF7 Cells Expressing Both or Either of the N- and CTerminal Domains of MT-3
Earlier work in our laboratory indicated that the restoration of MT-3 expression in
the HK2 cell line led to an establishment of cellular junctions, vectorial active transport,
and a cadherin expression profile that is consistent with an epithelial phenotype (Bathula
et al. 2008) (Figure 3). One goal of this study was to observe if either the N- or Cterminal domain of MT-3 is responsible for the doming phenotype and if one domain
may attenuate the activity of the other. No doming activity was observed for the
following MCF7 cell lines: parent, Blank Vector, MT-1E, NT-1E, MT3ΔCT, or NT-CT1E (Table 1). The formation of domes in cell culture was observed in the following
MCF7 cell lines: WT MT-3, MT3ΔNT, and CT-1E (Table 1). In doming MCF7 cell
lines more domes per field of view were observed in cell lines possessing only the Cterminal region of MT-3 (Figure 6). Domes were observed per one field of view that was
1.9 cm2 using a 10x objective lens and the cellSens® microscope imaging software
(Olympus, MA). A total of twenty one fields of view were observed for each doming
cell line and the number of observed domes (Figure 7). Overall an average of 51.89 +/7.89, 57.22 +/- 5.46, and 56.44 +/- 1.602 domes were observed when adding all twentyone fields of view for WT MT-3, MT-3ΔNT, and CT-1E MCF7 mutant cell lines
respectively (Table 1) (Figures 8-10). Domes per field of view averaged 2.69 for the CT1E cell line, wild type MT-3 had an average of 2.47 domes per field of view, and MT3ΔNT averaged 2.72 domes per field of view (Table 1).
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Figure 6: Images of MCF7 cells and MCF7 mutant cell lines doming in culture.
Domes are indicated by white arrows. A: MCF7 parent. B: MCF7 CT-1E. C and D:
MCF7 MT-3 cell line; C depicts a larger doming structure while D depicts several
smaller domes. E: MCF7 MT-3ΔNT. F: MCF7 MT-3ΔNT. Image taken 10 days after
cells were passaged and seeded at a 1:3 ratio. Magnification of 100x
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Figure 7: Domes observed per 21 fields of view in a T-25 cell culture flask. MCF7
WT MT-3 averaged 51.89 +/- 7.89 domes per flask, MT-3ΔNT averaged 57.22 +/- 5.46
domes per T-25 cell culture flask, and CT-1E averaged 56.44 +/- 1.60 domes per flask.
Domes were not observed in the MCF7 parent, MT-3ΔCT, NT-1E, and MT-1E cell lines.
No significant difference was determined among doming cell lines using the one-way
ANOVA test.
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MCF7 Cell Line Domes Observed
in Cell Culture

Average Number of
Domes Observed
per Field of View

WT MT-3
MT-3ΔNT
MT-3ΔCT
MT-1E
CT-1E
NT-1E
NT-CT-1E
Parent
Blank Vector

2.47
2.72
0
0
2.69
0
0
0
0

Yes
Yes
No
No
Yes
No
No
No
No

Average Number
of Domes
Observed per 21
Fields of View
51.89
57.22
0
0
56.44
0
0
0
0

Table 1: Doming phenotype and domes observed for MCF7 mutant cell lines. Table
indicates if domes were observed for each MCF7 mutant cell line. Average number of
domes observed per field of view and per 21 fields of view for doming cell lines is also
displayed.
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Figure 8: Image of the MCF7 CT-1E mutant cell line depicting dome formation.
Domes appear as out of focus areas in relation to confluent cells still attached to the
culture vessel, and are indicated by white arrows. Image taken 10 days after cells were
passaged and seeded at a 1:3 ratio.

Magnification of 100x.
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Figure 9: Image of the MCF7 WT MT-3 mutant cell line depicting dome formation.
Domes appear as out of focus areas in relation to confluent cells still attached to the
culture vessel, and are indicated by white arrows. Image taken 10 days after cells were
passaged and seeded at a 1:3 ratio. Magnification of 100x.
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Figure 10: Image of the MCF7 MT-3ΔNT mutant cell line depicting dome
formation. Domes appear as out of focus areas in relation to confluent cells still attached
to the culture vessel, and are indicated by white arrows. Image taken 10 days after cells
were passaged and seeded at a 1:3 ratio.

Magnification of 100x.
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Doubling Times of MCF7 Cells Expressing Both or Either the N- and C-terminal
Domains of MT-3
Metallothionein-3 is not expressed in normal breast epithelial cells, but is highly
expressed in the majority of breast tumor samples (Sens et al. 2001). Expression of MT3 in MCF7 or Hs 578T cells results in growth inhibition (Gurel et al. 2003) and increased
chemotherapy drug resistance in MCF7 cells (Dutta et al. 2002). The role of MT-3 and
its unique N- and C-terminal domains plays in the differentiation of breast cancer has yet
to be fully described, and here we examine each domain’s individual effect on MCF7’s
growth rate. MCF7 parent cells have a standard doubling time of 29 h (ATCC, MCF7),
however in our laboratory we found that the doubling time for the MCF7 cells was 32.45
h. MCF7 cells expressing the MT-1E and Blank Vector construct had observed doubling
times of 35.76 +/- 4.74 h and 39.51 +/- 5.96 h respectively. As a control group MCF7
parent, MCF7 MT-1E, and MCF7 Blank Vector had no statistically significant change in
observed doubling times. MCF7 cell lines containing the following constructs WT MT3, MT-3ΔNT, MT-3ΔCT, CT-1E, NT-1E, and NT-CT-1E had observed doubling times
of 53.1 +/- 2.2, 57.31 +/- 3.83, 64.73 +/- 5.24, 55.28 +/- 11.25, 60.96 +/- 3.3, and 56.96
+/- 5.8 h respectively. All cell lines possessing the N-terminal region, C-terminal region,
or both the N- and C-terminal regions of WT MT-3 had a doubling time that was
observed to be significantly slower than the control cell lines parent MCF7, MT-1E, and
Blank Vector (Figure 11).
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Figure 11: MCF7 mutant cell line doubling times. All mutant cell lines had increased
doubling times in comparison to MCF7 parent except the MT-1E, and MCF7 Blank
Vector cell lines. Statistical significance indicated by **, ***, or **** P-value less than
0.01, 0.001, and 0.0001 respectively using the one-way ANOVA followed by Tukey’s
posttest comparing all mutant cell lines to MCF7 Parent. Error bars represent SD. Three
biological replicates were tested.
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Evidence of a differentiated phenotype for cell lines possessing the C-terminal of MT-3
can be observed morphologically by the formation of domes in cell culture (Figures 6, 8,
and 10) (Table 1), and by the increase in TER (Figure 12).
Transepithelial Resistance of MCF7 Cells Expressing Both or Either the N- and CTerminal Domains of MT-3
The integrity and permeability of a cell monolayer can be measured using
transepithelial resistance (TER). Measuring TER is a well-established method to
determine the presence of tight junctions along with ionic permeability (Stevenson 1988).
Expression of MT-3 in HK2 cells resulted in an increase in TER, dome formation, and
the expression of E-cadherin indicating the formation and maintenance of cell to cell
junctions characteristic of an epithelial cell (Bathula et al. 2008). Alterations in TER
based on the N- or C-terminal of MT-3 were examined in MCF7 cells to determine if
either domain or both contribute to the formation of a differentiated epithelial cell type.
The daily average TER on days five, six, and seven varied to a large degree
amongst the MCF7 mutant cell lines (Table 2). This indicates that dome formation and
the tight junctions associated with the epithelial phenotype may form and re-form as the
monolayer is formed in MCF7 cells. The combined average TER on days five, six, and
seven post-seeding were used to compare all MCF7 cell lines. The MCF7 parent cell line
had a TER of 17.57 +/- 4.35 Ω/Cm2 and WT MT-3 had the highest average TER of 48.72
+/- 6.79 Ω/Cm2. MCF7 cell lines MT-1E, Blank Vector, MT-3ΔNT, MT-3ΔCT, CT-1E,
NT-1E, and NT-CT-1E had TER averages from days five to seven post seeding of: 33.17
+/- 1.47, 21.64 +/- 5.62, 47.58 +/- 5.55, 32.87 +/- 5.62, 30.09 +/- 4.35, 34.72 +/- 2.67, and
51.19 +/- 7.75 Ω/Cm2 respectively (Table 2). It was observed that TER over seven days
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of measurements was typically higher for cells possessing the C-terminal domain of MT3 (Figure 12). When compared to the MCF7 parent cell line WT MT-3, MT-3ΔNT, and
NT-CT-1E mutant cell lines had a significant increase in TER. The average TER from
day 5 indicated no significant increase using the MCF7 parent cell line as the control (
Figure S3), in the case of day 6 the NT-CT-1E cell line had a significant increase in TER
in comparison to the parent cell line (Figure S4). On day 7 the WT MT-3, MT-3ΔNT,
and NT-CT-1E had significantly increased TER measurements in comparison to the
MCF7 parent cell line (Figure S5).
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Figure 12: Average TER from days 5, 6, and 7 post seeding on trans-well inserts.
Each MCF7 mutant cell line is represented on the x axis, while the calculated TER is
displayed on the y axis. Increased TER is indicative of the formation of tight junctions,
and is associated with the doming phenotype. Statistical significance indicated by ** Pvalue less than 0.01 using the one-way ANOVA test and Dunnet’s posttest for multiple
comparisons using the MCF7 parent cell line as a control. Error bars represent SD.
Three biological replicates were tested.
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MCF7 Cell
Line

Average TER
Day 5
(Ω/Cm2)

Average TER
Day 6 (Ω/Cm2)

Average TER
Day 7 (Ω/Cm2)

WT MT-3

35.32 +/- 5.81

53.57 +/- 13.88

52.27 +/- 12.11

MT-3ΔNT

41.99 +/- 9.26

53.08 +/- 9.57

47.67 +/- 5.16

MT-3ΔCT

26.39 +/- 1.99

44.06 +/- 3.37

28.16 +/- 5.87

MT-1E

32.68 +/- 7.26

35.92 +/- 6.98

30.91 +/- 8.41

CT-1E

22.96 +/11.94
37.58 +/10.23
37.91 +/12.10
18.80 +/- 1.46

29.34 +/- 9.40

37.98 +/- 7.07

34.3 +/- 9.4

32.28 +/- 12.61

64.76 +/- 5.95

50.91 +/- 14.26

22.27 +/- 4.63

8.96 +/- 1.92

27.38 +/- 10.76

36.80 +/- 6.48

NT-1E
NT-CT-1E
Parent

Blank Vector 41.99 +/- 5.38

Average
TER Day 5,
6, and 7
(Ω/Cm2)
48.72 +/6.79
47.58 +/5.55
32.87 +/5.62
33.17 +/1.47
30.09 +/4.35
34.72 +/2.67
51.19 +/7.75
17.57 +/4.35
35.39 +/5.62

Table 2: Average TER for MCF7 mutant cell lines for days 5, 6, and 7. Table
indicates the average TER for each MCF7 mutant cell line for days 5, 6, and 7 expressed
as Ω/Cm2 and indicating the SEM. The combined average TER of days 5, 6, and 7 is
used to evaluate the relationship between TER and the presence or absence of the N- and
C-terminal of MT-3. Three biological replicates were tested.
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Microarray Analysis of MCF7 Cells Expressing Both or Either the N- and C-terminal
Domains of MT-3
The function of WT MT-3 and its N- and C-terminal domains in the
differentiation of breast cancer remains to be fully elucidated. Microarray analysis and
subsequent investigation into differentially expressed genes (DEGs) could indicate
important cellular pathways that become altered based on the presence or absence of WT
MT-3 and its unique N-and C-terminal domains. All the MCF7 mutant cell lines, except
NT-CT-1E, underwent microarray analysis in order to determine DEGs. Overlap
hierarchical clustering demonstrates that the N- and C-terminal domains have unique
expression relationships based on clustering dendrogram (Figure 13). Mutants
possessing either the N- or C-terminal regions also grouped together on the clustering
dendrogram suggesting a similar pattern of gene expression among cell lines containing
the same terminal regions (Figure 13). Differentially regulated genes from microarray
analysis that were significantly altered compared to Blank Vector as a control include:
NELL2, PAPSS2, PYGL, VGSC, and LRRC49. The GAGE antigen family was also
found to be differentially regulated on the microarray uniquely by the N- or C-terminal
domains of MT-3.
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Figure 13: Cluster dendrogram of MCF7 mutant cell lines. Clustering determined
using the Overlap Hierarchal Clustering based on differentially expressed genes.
Clustering demonstrates that cells possessing the N- or C-terminal took residence in
different areas of the diagram. The proximity of one cell line to another indicates the
degree of difference in gene expression. Closer cell lines being more similar and further
being more different.
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Differential Expression Analysis of LRRC49, NELL2, PAPSS2, PYGL, VGSC, and
MMP-1 in MCF7 Cells Expressing Both or Either the N- and C-terminal Domains of
MT-3
Microarray analysis indicated that LRRC49 expression had a 4.46 fold increase in
the MCF7 WT MT-3 cell line, a 4.35 fold increase in the MCF7 MT-3ΔNT cell line, a
5.53 fold increase in the NT-1E cell line, and a 1.54 fold increase in the CT-1E cell line.
Expression of the NELL2 gene in MCF7 MT-3ΔNT and CT-1E mutant cell lines was
induced by 1.2 fold and 1.07 fold respectively. In the MCF7 WT MT-3, MT-3ΔNT, and
CT-1E cell lines PAPSS2 expression was increased 1.22, 1.55, and1.35 fold respectively.
Repression of PYGL occurred in the MCF7 MT-3ΔNT and CT-1E mutant cells lines
where expression was .98 and .83 of the control respectively. The VGSC family member
SCNN1A was upregulated 2.35 fold in the MCF7 NT-1E cell line. The previously
mentioned genes underwent validation using qualitative real time PCR and were
normalized to beta actin. Validation data indicated that none of the genes were
significantly up or down-regulated in any of the MCF7 mutant cell lines. Based on
microarray data from the HK2 MT-3 cell line, MMP-1 was also investigated in all the
MCF7 mutant cell lines. Qualitative real time PCR demonstrated that MMP-1 was
significantly up-regulated 5.33 fold in the MCF7 NT-CT-1E cell line (Figure 14) using
MCF7 Blank Vector as the control.
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Figure 14: Fold change in expression of the MMP-1 in MCF7 mutant cell lines. Data
suggests that the presence of MT-3 may increase the expression of MMP-1 as indicated
by the significant increase in expression of MMP-1 in the MCF7 NT-CT-1E mutant cell
lines when compared to the MCF7 Blank Vector and MT-1E cell lines. Statistical
significance indicated by ** P-value less than 0.01. Significance determined using oneway ANOVA and Dunnet’s posttest. Error bars represent SD. Three biological
replicates were tested.
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GAGE Family Antigens are Differentially Expressed Based on the Presence or Absence
of the N- and C-terminal Domains of MT-3
Recent evidence suggests that the GAGE family antigens may direct cell
proliferation, differentiation, and the survival of germ line cells (Simpson et al. 2005).
To determine if the N- or C-terminal of MT-3 can differentially regulate genes, the
microarray was examined for genes up- or down-regulated by one terminal being present
and the opposite effect happening for the other terminal. The GAGE family antigens
were found to be down-regulated by WT MT-3 and when the N-terminal-only mutants,
NT-1E and MT-3ΔCT, were present (Figures 15-22). For several GAGE family antigens
when the C-terminal-only cell line CT-1E was present expression significantly increased
(Figures 15-22) in comparison to the Blank Vector cell line. The microarray analysis
indicated that GAGE12H, GAGE12G, GAGE6, and GAGE12F were differentially
regulated by the N- or C-terminal of MT-3. Additional GAGE family antigens were also
tested by real time PCR. Genes that were validated include GAGE12H, GAGE12G,
GAGE4, GAGE5, GAGE6, GAGE2C, GAGE2E-1, and GAGE2E-2. Due to a suitable
primer being unavailable GAGE12F was not validated.
Using the MCF7 Blank Vector as a control, the relative changes in expression
were determined from the microarray for the GAGE antigen family. The MCF7 WT
MT-3 cell line had repression of GAGE12H, GAGE12G, and GAGE6 to 0.93, 0.82, and
0.85 respectively. In the MCF7 MT-3ΔNT GAGE12F was upregulated 1.45 fold. The
MCF7 MT-3ΔCT cell line had repression of GAGE12H, GAGE12G, GAGE4, GAGE5,
GAGE6, and GAGE12F to 0.52, 0.41, 0.46, 0.47, 0.43, and 0.62 respectively.
Repression was again seen the N-terminal containing MCF7 NT-1E cell line where
GAGE12H, GAGE12G, GAGE4, and GAGE6 expression levels were 0.66, 0.58, 0.64,
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and 0.63 respectively of control. For the C-terminal containing MCF7 CT-1E cell line
there was an increase in expression for GAGE12H, GAGE12G, GAGE5, and GAGE12F
genes of 2.55, 2.78, 2.93, and 3.27 respectively of control. The GAGE12F gene was the
only GAGE family antigen appearing on the microarray for the MCF7 MT-1E cell line
and was up-regulated 1.23 fold.
Validation of the GAGE family antigens using real time PCR confirmed a pattern
of up regulation in the presence of the MCF7 CT-1E cell line for the majority tested. The
GAGE2C, GAGE5, and GAGE12H were all significantly down-regulated in MCF7 WT
MT-3, MT-3ΔCT, and NT-1E cell lines. Those same genes were all significantly
upregulated in MCF7 MT-1E and CT-1E mutant cell lines (Figures 15, 16, and 19). The
N-terminal cell lines MCF7 MT-3ΔCT and NT-1E along with WT MT-3 had the
GAGE2E-2, GAGE6, and GAGE2E-1 genes significantly down-regulated (Figures 15,
16, and 18). For the MCF7 mutant cell lines containing the C-terminal GAGE2E-1 was
significantly up-regulated in the MT-3ΔNT cell line (Figure 16), as was GAGE12G
(Figure 20) and GAGE2E-2 (Figure 17). Validation indicated that GAGE4, GAGE12G,
and GAGE2E-2 were all significantly upregulated in the MCF7 cell lines expressing MT1E and CT-1E (Figures 16, 18, and 21). The GAGE6 antigen was also significantly upregulated in the MCF7 CT-1E mutant cell line (Figure 19).
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Figure 15: Expression of GAGE2C gene in various MT mutants in MCF7 cells.
Fold change in expression of the GAGE2C antigen in MCF7 mutant cell lines using
Blank Vector as the control. Statistical significance indicated by **** P-value less than
0.0001. Significance determined using one-way ANOVA and Tukey’s posttest. Error
bars represent SEM. Three biological replicates were tested.
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Figure 16: Fold change in expression of the GAGE2E-1 antigen in MCF7 mutant
cell lines. Changes in fold expression were measured using MCF7 blank vector as the
control. Statistical significance indicated by ** or **** P-value less than .01, .0001
respectively. Significance determined using one-way ANOVA and Tukey’s posttest.
Error bars represent SEM. Three biological replicates were tested.
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Figure 17: Fold change in expression of the GAGE2E-2 in MCF7 mutant cell lines.
Changes in fold expression were measured using MCF7 blank vector as the control.
Statistical significance indicated by *, ***, or **** P-value less than .05, .001, and .0001
respectively. Significance determined using one-way ANOVA and Tukey’s posttest.
Error bars represent SEM. Three biological replicates were tested.
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Figure 16: Fold change in expression of the GAGE4 in MCF7 mutant cell lines.
Changes in fold expression were measured using MCF7 blank vector as the control.
Statistical significance indicated by ** or **** P-value less than .01, and .0001
respectively. Significance determined using one-way ANOVA and Tukey’s posttest.
Error bars represent SEM. Three biological replicates were tested.
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Figure 19: Fold change in expression of the GAGE5 in MCF7 mutant cell lines.
Changes in fold expression were measured using MCF7 blank vector as the control.
Statistical significance indicated by **** P-value less than .0001. Significance
determined using one-way ANOVA and Tukey’s posttest. Error bars represent SEM.
Three biological replicates were tested.
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Figure 20: Fold change in expression of the GAGE6 in MCF7 mutant cell lines.
Changes in fold expression were measured using MCF7 blank vector as the control.
Statistical significance indicated by ** or *** P-value less than .01, and .001
respectively. Significance determined using one-way ANOVA and Tukey’s posttest.
Error bars represent SEM. Three biological replicates were tested.
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Figure 21: Fold change in expression of the GAGE12G in MCF7 mutant cell lines.
Changes in fold expression were measured using MCF7 blank vector as the control.
Statistical significance indicated by ** or **** P-value less than .01, and .0001
respectively. Significance determined using one-way ANOVA and Tukey’s posttest.
Error bars represent SEM. Three biological replicates were tested.
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Figure 22: Fold change in expression of the GAGE12H in MCF7 mutant cell lines.
Changes in fold expression were measured using MCF7 blank vector as the control.
Statistical significance indicated by *, **, or **** P-value less than .05, .01, and .0001
respectively. Significance determined using one-way ANOVA and Tukey’s posttest.
Error bars represent SEM. Three biological replicates were tested.
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CHAPTER IV

DISCUSSION

The Role of MT-3 in Transcriptional Regulation of E-cadherin

A hallmark of the transition between epithelial and mesenchymal cell types is in
the inverse expression of E- and N-cadherin (Bathula et al. 2008). Loss of E-cadherin
expression is one of the events prior to a cell becoming mesenchymal, while induction of
E-cadherin is needed for the formation of adherens junctions and a complete epithelial
layer. The HK2 cell line has no basal expression of MT-3 and is non-doming; however
restoration of MT-3 expression increases E-cadherin expression and creates a doming
phenotype (Bathula et al. 2008). Transcriptional regulation of E-cadherin has also been
shown be repressed by the E-box binding transcription repressors Slug and Snail (Batlle
et al. 2000). Transcription repressors Slug and Snail bind E-box elements CAGGTG,
TCACCTG, and CACCTG and mutation of those sequences to AACCTA, AACCTA,
and AACCTA prevents the binding and E-cadherin expression increases (Batlle et al.
2000). The role of MT-3 in the regulation of E-cadherin expression was examined using
a WT E-cadherin promoter and one with four mutated E-boxes. Expression of MT-3 in
HK2 cell lines caused a significant increase in the expression of E-cadherin in the case of
the WT promoter and the promoter containing mutated E-boxes (Figure 5). The presence
of MT-3 appears to have an additive effect increasing the expression of E-cadherin
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beyond the baseline expression for the construct containing the mutated E-boxes. If MT3 functioned to regulate E-cadherin expression by interacting with E-box elements it
would be expected that the expression would not increase once the E-box elements had
been mutated. Data suggest that 36 hours post-transfection MT-3 up-regulates Ecadherin expression and this is not wholly mediated by E-box repression. It is likely that
MT-3 is indirectly up-regulating E-cadherin expression and not independently interacting
with the promoter.

The Role of MT-3 in MCF7 Cell Differentiation

Studies have demonstrated that MT-3 is involved in the maintenance of vectorial
active ion transport in human proximal tubule cells (Kim 2002), and that restoration of
MT-3 expression in HK2 cells confers the doming phenotype (Bathula et al. 2008). The
doming phenotype indicates that cell cultures derived from transporting epithelial cells
have retained vectorial active transport activity (Lever, 1985). Domes appear in cell
culture vessels as out of focus in relation to the monolayer indicating they are raised and
detached from the cell culture vessel due to water following transported ions in the
basolateral surface. This study demonstrated that MCF7 cells differentiated into a
doming phenotype when the C-terminal of MT-3 was present (Figures 6, 8, 9 and 10).
Cell lines able to form domes had no significant difference in the visible doming activity
when compared to other cell lines possessing the doming phenotype (Figure 7). Utilizing
TER measurements is an established method to determine the presence of tight junctions
and ionic permeability of the cell monolayer (Kang et al. 2015). Transepithelial
resistance measurements were significantly higher in the MCF7 mutant cell lines WT
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MT-3, MT-3ΔNT, and NT-CT-1E when compared to the parent MCF7 cell and the MT1E cell line (Figure 12). The findings indicate that the C-terminal of MT-3 may be
responsible for the formation of tight junctions and conferring the doming phenotype, but
that the C-terminal alone may not lead to significant increase in TER as indicated by the
MCF7 mutant cell line CT-1E (Figure 12).

The N-terminal of MT-3 contains a Thr residue that is not present in any of the
other MT isoforms (Andrews 2000; Aschner et al. 1997; Kagi and Hunziker 1989). It has
been demonstrated that this Thr is responsible for the growth inhibitory activity
associated with MT-3 (Kagi and Hunziker 1989). Addition of MT-3 to cultured rat
cortical neurons inhibits survival and neurite outgrowth, and elevating the expression of
MT-3 in rat C-6 glial cells also confers growth inhibitory activity (Tsuji et al. 1992).
This growth inhibitory activity is unique to MT-3 and despite a 63-69% sequence identity
no other MT isoforms confer growth inhibition (Aschner et al. 1997). The growth
inhibitory activity of MT-3 also occurs in MCF7 and Hs578T cells, but not to the MDAMB-231 and T-47D cell lines (Gurel et al. 2003c). This study examined the doubling
time of MCF7 cells expressing WT MT-3, MT-1E, and mutant forms containing either
the N-terminal or C-terminal domains of MT-3 and both the N- and C-terminal of MT-3
(Figure 3). The MCF7 WT MT-3, MT-3ΔNT, MT-3ΔCT, CT-1E, and NT-1E cell lines
had a significant increase in doubling time in comparison to the parent MCF7 cell line
and Blank Vector (Figure 11). The MCF7 MT-1E cell line did not have a significant
change in doubling time when compared to the parent MCF7 and Blank Vector cell lines.
The growth inhibition of cell lines containing the C-terminal of MT-3 but not the Nterminal may be due the C-terminal domain initiating differentiation of the cell line into a
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more epithelial phenotype as indicated by dome formation in cell culture (Figures 6-10)
and increased TER (Figure 12).

Overexpression of MT-3 occurs in breast cancers and esophageal cancers (Somji
et al. 2010; Tian et al. 2013) that have a poor prognosis. The presence of MT-3 may
serve as a protective mechanism inhibiting cellular proliferation by altering the
expression of other genes (Tian et al. 2013). Microarray analysis and overlap
hierarchical clustering implicated that there were unique alterations in gene expression
based on the presence or absence of the N- or C-terminal of MT-3 (Figure 13). Further
investigation of up or down-regulated genes based on the microarray included: PAPSS2,
MMP-1, LRRC49, NELL2, PYGL, VGSCs, and the family of GAGE antigens. The
protein LRRC49 has been shown to have elevated expression levels in ER+ breast
cancers compared to ER- breast cancers (De Souza Santos et al. 2008), and NELL2 is
over expressed in Burkitt’s lymphoma and in neuroblastomas (Maeda et al. 2001).
Overexpression of PAPSS2 in MCF7 cells has been shown to slow cellular proliferation
by arresting cell cycle progression and inducing apoptosis (Xu et al. 2012), while down
regulation of PYGL can cause cancer cells to undergo senescence (Favaro et al. 2012).
Expression of the VGSCs Nav1.6 and Nav 1.7 occurs in prostate cancer cell lines and
other metastatic cells (Shan et al. 2014). Although significant alterations in expression of
NELL2, PAPSS2, PYGL, VGSCs, and LRRC49 was indicated by microarray analysis
real time PCR indicated there was no significant changes in expression for those genes in
comparison to MCF7 Blank Vector as a control. During carcinogenesis MMPs act as
mediators of alterations observed in the microenvironment during both early and late
stages of disease progression (Yadav et al. 2014). The MCF7 mutant cell line NT-CT-1E
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had a significant increase in the expression of MMP-1 using MCF7 Blank Vector as a
control (Figure 14). An over-expression of MT-3 and subsequent increased expression of
MMP-1 may be indicative of disease progression.

The N-and C-terminal of MT-3 Differentially Regulate the Expression of GAGE
Antigens
The exact biological function of the GAGE antigens remains unknown recent
evidence suggests that they may direct cell proliferation, differentiation, and the survival
of germ line cells (Simpson et al. 2005), additionally antiapoptotic properties have also
been attributed to GAGE antigens (Cilensek et al. 2002). The presence of GAGE
antigens in various aggressive carcinomas makes any alteration in expression of interest
(Cheung, Chi, Cheung 2000; Kong et al. 2004; Zambon et al. 2001). Microarray analysis
indicated that the expression of GAGE antigens in MCF7 mutant cell lines was downregulated when the N-terminal of MT-3 was present and up-regulated when the Cterminal alone was present. Real time PCR on several family members of the GAGE
antigens supported that finding (Figures 15-22).
Data suggests that the presence of the N-terminal of MT-3 may repress the
expression of GAGE2C and GAGE2E-1 as indicated by the significant reduction in
expression of GAGE2C and GAGE2E-1 in WT MT-3, MT-3ΔCT, and NT-1E MCF7 cell
lines (Figures 15-16). Lack of the N-terminal restores expression of GAGE2E-1 to
control levels with the exception of the MT-3ΔNT mutant cell line which exhibits
repression in comparison to the blank vector cell line (Figure 16). Real time PCR
suggests that the presence of the N-terminal of MT-3 may repress the expression of
GAGE2E-2 since there is significant reduction in expression of GAGE2E-2 in WT MT-3,
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MT-3ΔCT, and NT-1E (Figure 17). The presence of any MT lacking the N-terminal of
MT-3 may induce the expression of GAGE2E-2 as indicated by the MT-1E, MT-3ΔNT,
and CT-1E mutant cell lines which exhibit increased expression in comparison to the
Blank Vector cell line (Figure 17). The C-terminal of MT-3 may induce the expression
of GAGE4 and GAGE5 as indicated by the significant increase in expression of GAGE4,
GAGE 5, and GAGE12H in the MCF7 CT-1E cell line (Figures 18, 19, 22).
Metallothioneins may also induce GAGE4, GAGE5, and GAGE12H antigen expression
as indicated by the increase seen in the MT-1E cell line (Figures 18, 19, 22). The
presence of the N-terminal of MT-3 may repress the expression of GAGE5 as indicated
by the significant reduction in expression of GAGE5 in WT MT-3, MT-3ΔCT, and NT1E MCF7 cell lines (Figure 19). Data suggests that the presence of the C-terminal of
MT-3 may induce the expression of GAGE6 as indicated by the significant increase in
expression of GAGE6 in CT-1E cell line. The N-terminal of MT-3 may be responsible
for repressing the expression of GAGE6 since WT MT-3, MT-3ΔCT, and NT-1E all have
decreased levels of GAGE6 mRNA (Figure 20). Expression of GAGE12G had a
significant increase in expression in MT-1E, MT-3ΔNT, and CT-1E MCF7 mutant cell
lines (Figure 21). The N-terminal of MT-3 may be responsible for repressing the
expression of GAGE12H since WT MT-3, MT-3ΔCT, and NT-1E all have suppressed
levels of GAGE12H mRNA in those cell lines (Figure 22).
Wild type MT-3 consistently down-regulated GAGE antigen expression despite
having both the N- and C-terminals present suggesting that the N-terminal of MT-3 was
actively altering gene expression in the MCF7 cell line. The GAGE antigens were often
up-regulated in the MCF7 CT-1E mutant cell line as was the MCF7 MT-1E cell line.
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This may indicate the metallothioneins may differentially up regulate GAGE antigen
expression, while the N-terminal of MT-3 is able to down regulate expression of those
same antigens.
Increased expression of E-cadherin is indicative of an epithelial phenotype while
the over-expression of N-cadherin coupled with down-regulation of E-cadherin indicates
a transition to a more mesenchymal state. Data indicates that in the HK2 cell line
expression of MT-3 re-establishes the expression of E-cadherin and subsequently the
cells differentiate into an epithelial phenotype. Data from this study suggests that MT-3
up regulates E-cadherin expression independent of E-box elements and most likely
indirectly from E-cadherin promoter itself. No alteration in the expression of E-cadherin
and N-cadherin occurred in the MCF7 mutant cell lines as indicated by RT-PCR (data not
shown). However, the MCF7 cell line is known to maintain an epithelial phenotype.
The downstream effects of MT-3 expression in the progression and differentiation
of breast cancer are many, and could be dependent on which region, the N- or C-terminal,
is active. The antiapoptotic properties of GAGE antigens along with their potential
involvement in cell proliferation, survival of germline cells and differentiation correlates
to a role in cancer that allows the tumors to divide and survive. Data suggests that the Nterminal region if active may be able to reduce the expression of GAGE antigens, while
the presence of MTs may actually increase the presence of several GAGE antigens.
Overall the role that MT-3 and MTs play in the regulation of GAGE antigens needs to be
further evaluated. Since the GAGE antigens are normally expressed in immune
privileged tissues their overexpression in tumors allows them to be targeted by
immunotherapy treatments. These tumors though are highly heterogenic in terms of
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which GAGE antigens are present. It appears as though MTs may only upregulate a
subset of the family. Researchers may use the presence or absence of MTs to help pick
which GAGE antigens would be most beneficial to target during immunotherapy.
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APPENDICES

APPENDIX A

Abbreviations

°C

Degree Centigrade

BSA

Bovine Serum Albumin

Cd2+

Cadmium

cDNA

Copy of DNA made from mRNA
Dalton’s

Da

Dulbecco’s Modified Eagles’ Media

DMEM

DNA

Deoxyribonucleic Acid

ECM

Extracellular Matrix

EMT

Epithelial-to-Mesenchymal Transition

ER

Estrogen Receptor

MT

Metallothionein
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MT-1E

Metallothionein-1E

MT-3

Metallothionein-3

mRNA

Messenger RNA

MRE

Metal Response Element

µM

Micromolar

µL

Microliter

µg

Microgram

mL

Milliliter

mM

Millimolar

ng

Nanogram

PCR

Polymerase Chain Reaction

RNA

Ribonucleic Acid

RT-PCR

Reverse Transcriptase Polymerase Chain Reaction

Thr

Threonine

TE

Tris-EDTA
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TER

Transepithelial Resistance

RNA

Ribonucleic Acid

SD

Standard Deviation

SEM

Standard Error of the Mean

WT

Wild Type

Zn2+

Zinc
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APPENDIX B

Supplemental Figures

*

Supplemental Figure 23: Relative Expression of E-cadherin WT promoter for HK2
and HK2-MT-3 cells. The WT E-cadherin promoter construct was transfected into HK2
and HK2-MT-3 cell lines that are represented on the x axis. Data are expressed as a ratio
of the Luciferase signal to the Renilla signal on the y axis. Statistical significance
indicated by * P-value less than .05 as determined using the one-way ANOVA. Error
bars represent SEM. Three biological replicates were tested.
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*

Supplemental Figure 24: Relative Expression of E-cadherin Mutant E-boxes
promoter for HK2 and HK2-MT-3 cells. The E-cadherin promoter construct with
mutated E-boxes was transfected into HK2 and HK2-MT-3 cell lines that are represented
on the x axis. Data are expressed as a ratio of the Luciferase signal to the Renilla signal
on the y axis. Statistical significance indicated by * P-value less than .05 as determined
using the one-way ANOVA. Error bars represent SEM. Three biological replicates were
tested.
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Supplemental Figure 25: Average TER from Day 5 post seeding on trans-well
inserts. Each MCF7 mutant cell line is represented on the x axis, while the calculated
TER is displayed on the y axis. Increased TER is indicative of the formation of tight
junctions, and is associated with the doming phenotype. Error bars represent SD. Three
biological replicates were tested.
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Supplemental Figure 26: Average TER from day 6 post seeding on trans-well
inserts. Each MCF7 mutant cell line is represented on the x axis, while the calculated
TER is displayed on the y axis. Increased TER is indicative of the formation of tight
junctions, and is associated with the doming phenotype. Statistical significance indicated
by * P-value less than .05 using the one-way ANOVA test and Dunnet’s posttest for
multiple comparisons using the MCF7 parent cell line as a control. Error bars represent
SD. Three biological replicates were tested.
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Supplemental Figure 27: Average TER from day 7 post seeding on trans-well
inserts. Each MCF7 mutant cell line is represented on the x axis, while the calculated
TER is displayed on the y axis. Increased TER is indicative of the formation of tight
junctions, and is associated with the doming phenotype. Statistical significance indicated
by * P-value less than .05 using the one-way ANOVA test and Dunnet’s posttest for
multiple comparisons using the MCF7 parent cell line as a control. Error bars represent
SD. Three biological replicates were tested.
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